Selecta Biosciences Seals Up to $47.25M
Watertown, Mass.-based Selecta Biosciences Inc. has closed on up to $47.25 million financing round from investors including RUSNANO, a $10-billion Russian Federation fund. The funding will be used for research and development efforts around the company’s vaccines and immunotherapies. Selecta’s financing breaks down into a $22 million Series D, and additional funding up to $25.25 million for strategic activities in Russia, the company said.
27 October 2011•5 mins read
